• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉病变中活化平滑肌细胞与血管成形术后再狭窄的关系。

Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy.

作者信息

Simons M, Leclerc G, Safian R D, Isner J M, Weir L, Baim D S

机构信息

Charles A. Dana Research Institute, Boston, MA.

出版信息

N Engl J Med. 1993 Mar 4;328(9):608-13. doi: 10.1056/NEJM199303043280903.

DOI:10.1056/NEJM199303043280903
PMID:8429852
Abstract

BACKGROUND

Neointimal proliferation leading to restenosis frequently develops after coronary angioplasty. This process is associated with a change in vascular smooth-muscle cells from a contractile (quiescent) phenotype to a synthetic or proliferating (activated) one. We investigated whether the presence of activated smooth-muscle cells in coronary lesions at the time of coronary atherectomy predisposes patients to subsequent restenosis.

METHODS

We used in situ hybridization to study the expression of messenger RNA in coronary-atherectomy specimens from 20 patients. Plaque material was hybridized with a probe for the B isoform of human nonmuscle myosin heavy chain, a major nonmuscle myosin isoform in activated, but not quiescent, smooth-muscle cells. Angiographic follow-up data were obtained a mean (+/- SD) of 174 +/- 54 days after atherectomy in 16 of the 20 patients, and the extent of recurrent luminal narrowing was analyzed quantitatively. The presence of restenosis was assessed by exercise thallium scintigraphy in the other four patients.

RESULTS

Atherectomy specimens from 10 of the 20 patients showed hybridization with the probe, defined as the clustering of more than 20 silver grains per cell nucleus in more than 10 nuclei in five high-power fields (x250); specimens from the other 10 patients showed no such hybridization. At follow-up, restenosis had developed in 8 of the 10 patients with positive hybridization results, but was absent in 9 of the 10 patients with negative results (P = 0.007). The degree of late loss in luminal diameter was significantly higher in patients with positive hybridization results than in those with negative results (ratio of late loss to immediate gain after atherectomy, 0.76 +/- 0.3 vs. 0.36 +/- 0.3; P < 0.001).

CONCLUSIONS

We conclude that the expression of the B isoform of nonmuscle myosin heavy chain is increased in some coronary atherosclerotic plaques and that this increase in expression identifies a group of lesions at high risk for restenosis after atherectomy.

摘要

背景

冠状动脉血管成形术后常发生导致再狭窄的新生内膜增生。这一过程与血管平滑肌细胞从收缩(静止)表型转变为合成或增殖(激活)表型有关。我们研究了冠状动脉旋切术时冠状动脉病变中激活的平滑肌细胞的存在是否会使患者易发生随后的再狭窄。

方法

我们使用原位杂交技术研究了20例患者冠状动脉旋切术标本中信使核糖核酸的表达。斑块材料与针对人非肌肉肌球蛋白重链B亚型的探针杂交,该亚型是激活而非静止的平滑肌细胞中的一种主要非肌肉肌球蛋白亚型。在20例患者中的16例旋切术后平均(±标准差)174±54天获得血管造影随访数据,并对复发性管腔狭窄程度进行定量分析。另外4例患者通过运动铊闪烁显像评估再狭窄的存在情况。

结果

20例患者中有10例的旋切术标本显示与探针杂交,定义为在五个高倍视野(×250)中每个细胞核有超过20个银颗粒聚集在超过10个细胞核中;另外10例患者的标本未显示这种杂交。随访时,杂交结果为阳性的10例患者中有8例发生了再狭窄,而杂交结果为阴性的10例患者中有9例未发生再狭窄(P = 0.007)。杂交结果为阳性的患者管腔直径的晚期丢失程度显著高于杂交结果为阴性的患者(旋切术后晚期丢失与即刻获得的比值,0.76±0.3对0.36±0.3;P < 0.001)。

结论

我们得出结论,非肌肉肌球蛋白重链B亚型在一些冠状动脉粥样硬化斑块中的表达增加,并且这种表达增加确定了一组旋切术后再狭窄风险高 的病变。

相似文献

1
Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy.冠状动脉病变中活化平滑肌细胞与血管成形术后再狭窄的关系。
N Engl J Med. 1993 Mar 4;328(9):608-13. doi: 10.1056/NEJM199303043280903.
2
[Cellularity and ultrastructural characteristics of human atherectomy specimens: comparison between restenosis and primary stenotic tissue of coronary and peripheral lesions].[人体动脉粥样硬化斑块切除术标本的细胞构成及超微结构特征:冠状动脉及外周病变再狭窄组织与原发性狭窄组织的比较]
Z Kardiol. 1993 Aug;82(8):485-93.
3
Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy.
Circulation. 1992 Feb;85(2):543-53. doi: 10.1161/01.cir.85.2.543.
4
[Restenosis after coronary angioplasty: its pathogenesis and prevention].[冠状动脉血管成形术后再狭窄:其发病机制与预防]
Cardiologia. 1991 Dec;36(12 Suppl 1):309-20.
5
Preliminary clinical experience with the pullback atherectomy catheter and the study of proliferation in coronary plaques.
Can J Cardiol. 1998 Dec;14(12):1457-63.
6
Stenting alone versus debulking and debulking plus stent in branch ostial lesions of native coronary arteries.单纯支架置入术与减容术以及减容术联合支架置入术治疗冠状动脉原位分支开口病变的比较
Heart Vessels. 2004 Sep;19(5):213-20. doi: 10.1007/s00380-004-0778-4.
7
Lower restenosis rate with stenting following aggressive versus less aggressive rotational atherectomy.与不太积极的旋磨术相比,积极的旋磨术后进行支架置入的再狭窄率更低。
Catheter Cardiovasc Interv. 1999 Apr;46(4):406-14. doi: 10.1002/(SICI)1522-726X(199904)46:4<406::AID-CCD4>3.0.CO;2-Z.
8
Comparison of directional coronary atherectomy-based intervention and stenting alone in ostial lesions of the left anterior descending artery.基于定向冠状动脉斑块旋切术的干预与单纯支架置入术治疗左前降支开口病变的比较。
Chang Gung Med J. 2005 Oct;28(10):689-98.
9
Deposition of PG-M/versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty.PG-M/多功能蛋白聚糖的沉积是经皮腔内冠状动脉成形术后人类冠状动脉再狭窄的主要原因。
J Pathol. 1996 Nov;180(3):311-6. doi: 10.1002/(SICI)1096-9896(199611)180:3<311::AID-PATH657>3.0.CO;2-B.
10
Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic results.定向旋切术治疗冠状动脉支架内再狭窄:临床、血管造影及组织学结果
J Am Coll Cardiol. 1992 Dec;20(7):1465-73. doi: 10.1016/0735-1097(92)90438-s.

引用本文的文献

1
The trade-off of a long drug-eluting stent.长效药物洗脱支架的权衡
EuroIntervention. 2021 Mar 19;16(16):1297-1298. doi: 10.4244/EIJV16I16A232.
2
Nonmuscle myosin heavy chain-B expression in balloon-dilated and stented arteries: a study in the atherosclerotic Yucatan micropig.非肌肉肌球蛋白重链-B在球囊扩张和支架置入动脉中的表达:对动脉粥样硬化尤卡坦小型猪的一项研究
Neth Heart J. 2005 Jun;13(6):224-232.
3
Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma.
新型小富含亮氨酸重复蛋白 podocan 是平滑肌细胞迁移和增殖的负调节剂,调节新生内膜形成,并在人动脉粥样硬化斑块中表达。
Circulation. 2013 Nov 26;128(22):2351-63. doi: 10.1161/CIRCULATIONAHA.113.004634. Epub 2013 Sep 16.
4
Hydrostatic pressure independently increases elastin and collagen co-expression in small-diameter engineered arterial constructs.静水压独立增加小直径工程化动脉构建体中弹性蛋白和胶原蛋白的共表达。
J Biomed Mater Res A. 2011 Mar 15;96(4):673-81. doi: 10.1002/jbm.a.33019. Epub 2011 Jan 25.
5
RNA interference targeting embryonic myosin heavy chain isoform inhibited mRNA expressions of phenotype markers in rabbit cultured vascular smooth muscle cells.
Heart Vessels. 2007 Jan;22(1):41-7. doi: 10.1007/s00380-006-0929-x. Epub 2007 Jan 26.
6
Tyrosine phosphorylation of platelet derived growth factor beta receptors in coronary artery lesions: implications for vascular remodelling after directional coronary atherectomy and unstable angina pectoris.冠状动脉病变中血小板衍生生长因子β受体的酪氨酸磷酸化:对定向冠状动脉斑块旋切术和不稳定型心绞痛后血管重塑的影响
Heart. 1998 Apr;79(4):400-6. doi: 10.1136/hrt.79.4.400.
7
Anti-atherogenicity in women does not prevent restenosis after balloon angioplasty.
Heart Vessels. 1997;12(2):60-6. doi: 10.1007/BF02820868.
8
Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells.基底膜聚糖调节血管平滑肌细胞中Oct-1基因的表达。
Mol Biol Cell. 1997 Jun;8(6):999-1011. doi: 10.1091/mbc.8.6.999.
9
Characterization of the nonmuscle myosin heavy chain IIB promoter: regulation by E2F.非肌肉肌球蛋白重链IIB启动子的特性:受E2F调控
Gene Expr. 1996;6(1):45-57.
10
Differential response of rat aortic and coronary smooth muscle cell DNA synthesis in response to mechanical stretch in vitro.体外机械拉伸刺激下大鼠主动脉和冠状动脉平滑肌细胞DNA合成的差异反应。
In Vitro Cell Dev Biol Anim. 1996 Jan;32(1):13-5. doi: 10.1007/BF02722988.